CLIA Guidance During COVID-19 Emergency

March 30, 2020

CMS has issued important guidance ensuring that America’s clinical laboratories are prepared to respond to the threat of the 2019 Novel Coronavirus (COVID-19.) CMS is committed to taking critical steps to ensure America’s clinical laboratories are prepared to respond to the COVID-19 threat and other respiratory illnesses by implementing flexibility around requirements for a Clinical Laboratory Improvement Amendments (CLIA) certificate during public health emergencies.  Click here to view the FAQ sheet. CLIA-Laboratory-COVID-19-Emergency-FAQs_0.pdf (22 downloads)

 

 

 

Contact us today!